Our data provide a mechanistic explanation for the SGLT-1 upregulation in CF and in other human disease cellular models, and provide support to target the ER stress→XBP1→SLC5A1/SGLT-1 axis in these diseases. This evidence concerns the gene SLC5A1 and cystic fibrosis.